Five in every one hundred women suffer premenstrual symptoms at some time in their lives that are severe enough to interfere with their lives. One possible cause of the symptoms is the drop in progesterone that comes before menstruation. A suggested treatment, therefore, is to give women extra progesterone. But many health professionals doubt whether this treatment works.
To see if the research evidence can help resolve this, Cochrane Review Authors examined 17 different studies before performing a more detailed analysis of the data from the two trials which met their eligibility criteria. Of these, one trial of ‘better quality’ concluded that progesterone was more effective than placebo.
The main problem with assessing the benefit of progesterone is that 15 of the 17 trials had to be excluded for one or more important reasons. Some did not screen women for psychiatric disorders or persistence of symptoms after their menstrual periods, and others had to be excluded because the diagnosis of PMS was based on less than two cycles of symptom records. Probably because they needed to be run over many months, many trials also had a high drop out rate.
“The Review has revealed more about the difficulties inherent in the study of PMS and consequent deficiencies in method, than about the efficacy of progesterone in treating it,” says Lead Review Author Olive Ford former honorary Research Officer for the National Association for Premenstrual Syndrome.
Knowing whether progesterone is a useful treatment is complicated by the fact that treatments for PMS generally show large placebo effects. The Review Authors describe how some trials involving other therapies have found the placebo to have more effect than the treatment.
The Review points out that any women who do use progesterone need to be told of the mild side effects. These can include changes in menstrual cycle length and a tendency to become drowsy. In addition one woman who had believed herself to be infertile, conceived when taking progesterone, out of a total of about 650 women in all the trials examined.
Polly Young | alfa
Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State
NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences